ATE360817T1 - Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen - Google Patents

Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen

Info

Publication number
ATE360817T1
ATE360817T1 AT02102814T AT02102814T ATE360817T1 AT E360817 T1 ATE360817 T1 AT E360817T1 AT 02102814 T AT02102814 T AT 02102814T AT 02102814 T AT02102814 T AT 02102814T AT E360817 T1 ATE360817 T1 AT E360817T1
Authority
AT
Austria
Prior art keywords
carcinomas
detection
methods
compounds
treatment
Prior art date
Application number
AT02102814T
Other languages
English (en)
Inventor
Johannes Coy
Original Assignee
Coy Johannes F Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coy Johannes F Dr filed Critical Coy Johannes F Dr
Application granted granted Critical
Publication of ATE360817T1 publication Critical patent/ATE360817T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
AT02102814T 2002-12-18 2002-12-18 Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen ATE360817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02102814A EP1431762B1 (de) 2002-12-18 2002-12-18 Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen

Publications (1)

Publication Number Publication Date
ATE360817T1 true ATE360817T1 (de) 2007-05-15

Family

ID=32338157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02102814T ATE360817T1 (de) 2002-12-18 2002-12-18 Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen

Country Status (10)

Country Link
US (2) US20060121485A1 (de)
EP (1) EP1431762B1 (de)
JP (1) JP4527544B2 (de)
CN (1) CN1726393B (de)
AT (1) ATE360817T1 (de)
AU (1) AU2003302964A1 (de)
CA (1) CA2510150C (de)
DE (1) DE60219809T2 (de)
ES (1) ES2286201T3 (de)
WO (1) WO2004055514A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE360817T1 (de) * 2002-12-18 2007-05-15 Coy Johannes F Dr Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
DK2086642T3 (da) * 2006-10-18 2014-09-29 Periness Ltd Dnase til behandling af subfertilitet hos mænd
JP2008253188A (ja) * 2007-04-04 2008-10-23 Tokyo Univ Of Science エンドサイトーシス依存性ｄｎａ取り込み抑制剤、エンドサイトーシス依存性ｄｎａ取り込み促進剤、ウイルス感染阻害剤、ウイルス感染予防剤、及びウイルス感染促進剤、並びに、遺伝子マーカー、モノクローナル抗体、ハイブリドーマ、及びそれらの使用方法。
US7734161B2 (en) * 2007-04-19 2010-06-08 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Image stabilization with adaptive shutter control
WO2008154532A1 (en) * 2007-06-11 2008-12-18 California Pacific Medical Center Method and kit for dynamic gene expression monitoring
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
CN104267011A (zh) * 2014-09-23 2015-01-07 中国科学院东北地理与农业生态研究所 一种转基因羊卵母细胞的筛选方法
RU2726131C2 (ru) 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Внеклеточная днк в качестве терапевтической мишени при нейродегенерации
CN107677822A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 检测肿瘤标志物的荧光细胞计数检测试剂盒
CN107677823A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 一种用于检测肿瘤抗原的蛋白芯片试剂盒及其检测方法
CN107677820A (zh) * 2016-08-02 2018-02-09 北京金沐医疗科技有限公司 一种检测肿瘤抗原的试剂盒及其检测方法
EP3740581A4 (de) 2018-01-16 2021-10-27 CLS Therapeutics Limited Behandlung von krankheiten durch leberexpression eines enzyms mit desoxyribonuklease (dnase)-aktivität
CN109406771B (zh) * 2018-10-26 2023-04-07 安徽大千生物工程有限公司 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法
EP3997435A4 (de) * 2019-04-28 2024-03-13 Essenlix Corporation Schnelle pathologie/zytologie ohne waschen
EP4179116A4 (de) * 2020-07-13 2024-08-07 The Chinese University of Hong Kong Nukleaseassoziierte endsignaturanalyse für zellfreie nukleinsäuren
CN113314220B (zh) * 2021-07-28 2021-11-02 江苏为真生物医药技术股份有限公司 疾病病程监控系统、计算机可读存储介质以及电子设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19521046C1 (de) * 1995-06-09 1996-08-08 Deutsches Krebsforsch Protein mit DNase-Aktivität
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
EP1249495A1 (de) * 2001-04-11 2002-10-16 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Murine DNase X, diese enthaltendes Arzneimittel und nicht-menschliches Säugetier mit verändertem DNase X-Gen
JP2005512557A (ja) * 2001-11-07 2005-05-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー 遺伝子発現プロファイリングに基づく多発性骨髄腫の診断、予後、および治療標的候補の同定
CA2499709A1 (en) * 2002-06-19 2003-12-31 Yoichi Furukawa Method for diagnosis of colorectal tumors
ATE360817T1 (de) * 2002-12-18 2007-05-15 Coy Johannes F Dr Verbindungen und verfahren zur nachweiss von karzinomen und deren vorstufen

Also Published As

Publication number Publication date
ES2286201T3 (es) 2007-12-01
CA2510150C (en) 2017-11-07
AU2003302964A1 (en) 2004-07-09
US20080234393A1 (en) 2008-09-25
HK1086331A1 (zh) 2006-09-15
US8759004B2 (en) 2014-06-24
EP1431762B1 (de) 2007-04-25
CA2510150A1 (en) 2004-07-01
DE60219809T2 (de) 2008-01-17
JP2006510363A (ja) 2006-03-30
JP4527544B2 (ja) 2010-08-18
EP1431762A1 (de) 2004-06-23
DE60219809D1 (de) 2007-06-06
WO2004055514A1 (en) 2004-07-01
CN1726393A (zh) 2006-01-25
CN1726393B (zh) 2010-04-28
US20060121485A1 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
DE60219809D1 (de) Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
DE60029092D1 (de) Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
DE60319641D1 (de) Methode zur Anwendung Molekulare Konstrukte zur Detektion biochemischer Reaktionen
ATE275642T1 (de) Verfahren zur diagnose von krebs
ATE347306T1 (de) Vorrichtung und verfahren zur zufuhr und analyse von einer physiologischen flüssigkeit
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE60000583D1 (de) Verfahren zur identifizierung und/oder quantifizierung einer zielverbindung
KR20220151011A (ko) 분석물을 검출하기 위한 방법 및 조성물
DE602004031152D1 (de) Verfahren und system zum analysieren von reaktione
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
Casula et al. An innovative PCR-free approach for DNA methylation measure: An application for early colorectal cancer detection by means of an organic biosensor
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE429495T1 (de) Nukleinsäuren für die apoptose von krebszellen
ATE272214T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von s100b
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
DE60223149D1 (de) Nachweisverfahren mit biochip
DE50105971D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
MX2007008984A (es) Marcadores de cancer y metodos de deteccion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1431762

Country of ref document: EP